Amgen bought ChemoCentryx ChemoCentryx from 10/20/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Amgen completed its acquisition of ChemoCentryx for $3.7 billion, or $52 per share.

ChemoCentryx

Review

Source:

{source} pictogram

investors.amgen.com

Vladimir Petenev

News editor

Write your comment first

News feed

Rusagro scales up the Digital Farmer project

9/11/23 RAGR

Alrosa mined the largest diamond in 10 years

9/11/23 ALRS

The AbbVie announced a quarterly dividend

9/11/23 ABBV

Sollers launches production of ST6 pickup trucks

9/11/23 SVAV

PIK will build an industrial park in New Moscow

9/8/23 PIKK

Kamaz intends to install a hydrogen filling station in Naberezhnye Chelny for the waterbus project

9/8/23 KMAZ

Ozon launched its first logistics complex in the Far East

9/8/23 OZON

Rostelecom will receive a government directive on dividends in the near future

9/8/23 RTKM

Yandex resumes work on unmanned cars in the US

9/8/23 YNDX

Chizhik opened the chain's 1,000th store.

9/8/23 FIVE